NDATOPICALSOLUTION
Approved
Aug 2018
Lifecycle
Peak
Competitive Pressure
30/100
Data completeness
1/8 — Limited
Drug data last refreshed 12h ago · AI intelligence enriched 1mo ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
SOLUPREP S is a topical antiseptic solution combining chlorhexidine gluconate and isopropyl alcohol for skin preparation. It is used to reduce skin flora prior to surgical procedures and invasive medical interventions. The dual-agent formulation provides broad-spectrum antimicrobial activity for pre-procedural site antisepsis.
PeakPost-LOE
Product is at peak lifecycle with moderate competitive pressure (30); sales team focus likely on market penetration and hospital formulary management rather than launch expansion.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Career Relevance
Working on SOLUPREP S offers exposure to hospital/surgical center sales and formulary management in a mature, stable product. However, the impending patent expiration in 2026 limits long-term career stability on this brand.
Brand ManagerField Sales Representative
Worked on SOLUPREP S at Becton Dickinson? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.